Innovent Biologics, Inc.

Direct answer

Innovent Biologics, Inc. is publicly traded on HKSE under the ticker 1801.HK.

Innovent Biologics, Inc., established in 2011 and headquartered in Suzhou, People's Republic of China, functions as a leading biopharmaceutical enterprise. The company is dedicated to the comprehensive lifecycle of antibody drug candidates, encompassing their discovery, development, and eventual manufacturing. Its therapeutic focus spans critical areas such as oncology, ophthalmology, immunology, and metabolic...

Can you invest in Innovent Biologics, Inc.?

Yes. Innovent Biologics, Inc. is publicly traded on HKSE under the ticker 1801.HK.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Innovent Biologics, Inc.

Detailed equity research is provided by MarketSnap.